611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
FDA OKs Doptelet for Liver Dz Patients Undergoing ProceduresEven a Mosquito's Spit May Help Make You SickFDA Approves Aimovig to Prevent MigrainesLower Vitamin D levels Linked to More Belly FatCan the Mediterranean Diet Protect Against Smog-Related Deaths?Many Parents Say Restaurant Fare Has Made Kids Sick: PollVarious Clinical Disturbances Precede MS DiagnosisFDA Approves First Drug Aimed at Preventing MigrainesAcute Kidney Injury in Hospital Ups Risk of Later Heart FailurePools, Hot Tubs Can Harbor Dangerous GermsAHA: 'Ideal' Heart Health Eludes More AmericansOrgans From Opioid OD Victims Are Saving Lives: StudyMore Cases in Lettuce-Linked E. Coli Outbreak, But End May Be NearFremanezumab Linked to Fewer Monthly Migraine DaysNew Rabies Test Could Save Lives, Maybe Even Minus the ShotsHealth Tip: Understanding Childhood ArthritisFDA Approves 'Biosimilar' Drug to Treat Certain Types of AnemiaColon Polyp Type May Be Key to Cancer Risk'BioSimilar' Drug Approved to Treat Certain Types of AnemiaHealth Tip: Taming a Pollen AllergyHealth Tip: Identifying Asthma Triggers'Superbug' Surfaces at Poultry Farm in ChinaSun's UV Rays a Threat to Your Eyes, TooMalnutrition Is Associated With Poor Prognosis in Heart FailureAntibiotics Tied to Higher Kidney Stone RiskMore Doubt Cast on Surgery for Spinal Compression FracturesObesity Might Raise Your Risk for A-fibAffected by the EpiPen Shortage? Here's What to DoIs Testing for Zika in U.S. Blood Supply Worth the Cost?FDA Permits Marketing of New Device for Treating GI BleedingPTSD May Raise Odds for Irregular HeartbeatNew Device Cleared for Gastrointestinal BleedingIf Kids Exposed to Pot, Tobacco Smoke, ER Visits RiseEven Mild Concussion Tied to Greater Dementia Risk LaterHealth Tip: Help Prevent E coli InfectionCBD Oil: All the Rage, But Is It Really Safe and Effective?Low Neighborhood Walkability Increases Risk of Asthma in KidsSleep-Deprived Kids at Risk of ObesityStudy IDs Pain Descriptors for Varying Stages of Low Back PainHealth Tip: Prepare for a ColonoscopyFurther Signs That Too Much Sitting Can Raise Clot RiskLightning Can Affect Deep Brain Stimulation DevicesThe Cold Truth About Migraine HeadachesHealth Tip: When To Call Your Doctor If You Have Lower Back PainSkin's 'Good' Bacteria May Be Promising Weapon Against EczemaFirst Death Reported in E. Coli Outbreak Tied to Romaine LettuceVectorborne Diseases Up More Than Two-Fold From 2004 to 2016Health Tip: Recognizing Lung DiseaseBlood Type May Play Role in Death Risk After TraumaU.S. Illnesses Tied to Ticks, Mosquitoes Are Soaring
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

'Magnetic Pulse' Device May Be New Way to Prevent Migraines

HealthDay News
by By Alan Mozes
HealthDay Reporter
Updated: Apr 5th 2018

new article illustration

THURSDAY, April 5, 2018 (HealthDay News) -- Self-administered magnetic pulses from a hand-held device may help head off debilitating migraines, researchers report.

This new way to approach migraine headaches is called "single pulse transcranial magnetic stimulation" (sTMS). Neurologists and psychiatrists have long used the technology to diagnose and treat patients.

The U.S. Food and Drug Administration had already approved the eNeura SpringTMS device to treat the kind of in-progress migraines that are preceded by an "aura" of flashing lights and visual disturbances.

Having found that the device can also prevent up to half of all migraines from occurring in the first place, the FDA has now approved it for both prevention and treatment.

"The brain of a person with migraine, which is a neurologic disease with a genetic basis, is hyperexcitable," said lead researcher Dr. Amaal Starling. "In general, if we can reduce hyperexcitability, we can stop and/or prevent migraine attacks."

Transcranial magnetic stimulation does that by using energy created by a magnet to "change the electrical environment of neurons or brain cells," she explained.

Starling is an assistant professor of neurology with the Mayo Clinic in Scottsdale, Ariz.

She led a team that studied the effectiveness of the device, and the findings were published in the March issue of the journal Cephalalgia. The research was funded by eNeura, Inc., manufacturer of the device.

Migraines are the sixth-leading cause of global disability, affecting roughly 1 in 10 individuals. That includes an estimated 38 million people in the United States. The headaches are three times more common among women than men, according to the U.S. National Institute of Neurological Disorders and Stroke.

Migraines are marked by intense pulsing or throbbing pain in one part of the head, sometimes accompanied by nausea, vomiting and/or sensitivity to light and sound.

There's no known cure. Migraines are sometimes treated with drugs designed to target epilepsy, depression and high blood pressure. Injections of Botox (botulinum toxin A), stress management and relaxation techniques and exercise can help treat them.

To see if sTMS could prevent migraines, the researchers enlisted 263 patients between the ages of 18 and 65. Each kept a headache diary for one month. Some experienced auras with their headaches, others did not.

The participants were trained to use the sTMS device at home. It's roughly 3 inches by 9 inches in size and weighs about 3 pounds.

The patients were instructed to hold the device to the back of their head and press a button to administer the magnetic pulse. Migraine.com, a health forum website, says the sensation is mild but startling, though some find it uncomfortable.

To prevent migraines, the participants were told to give themselves four magnetic pulses -- each lasting less than a minute -- in the morning and four more at night. (Three sessions of three pulses every 15 minutes were prescribed for those with headaches in progress.)

The result? After three months, patients averaged three fewer headaches per month, regardless of migraine type. And 46 percent saw their headache frequency reduced by at least half.

Starling described the treatment as "well-tolerated." As headache frequency dropped, so did the use of migraine medications, she added. She would not estimate cost of the device, but predicted that FDA clearance would lead to broader insurance coverage.

Dr. Richard Lipton is director and vice chairman of neurology at Albert Einstein College of Medicine and director of the Montefiore Headache Center, both in New York City. He took part in the research that led to both FDA approvals.

Lipton said the aim is giving migraine sufferers more treatment options.

"Some people do not want to take drugs and prefer a device. Some people [also] do not respond to available drugs, or have side effects that limit their use," he said.

"For patients who prefer not to take drugs and for patients who have side effects or lack of medication response, this is an important [new] option," Lipton said.

More information

There's more on migraines at U.S. National Institute of Neurological Disorders and Stroke.